Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07504796
What this trial is testing

CtDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Who this might be right for
Metastatic MelanomaAdvanced Melanoma
NYU Langone Health 90
Testing effectiveness (Phase 2)UnknownNCT03917069
What this trial is testing

Nab-PCE vs PC for MM After Failure of Anti-PD-1

Who this might be right for
Advanced Melanoma
Peking University Cancer Hospital & Institute 145
Not applicableLooking for participantsNCT06685562
What this trial is testing

The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology

Who this might be right for
Breast Cancer PatientsMelanoma CancerProstate Cancer+1 more
Leiden University Medical Center 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03474497
What this trial is testing

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Who this might be right for
Non Small Cell Lung CancerMetastatic MelanomaMetastatic Renal Cell Carcinoma+1 more
Megan Daly, MD 18
Not applicableStudy completedNCT07429123
What this trial is testing

Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers

Who this might be right for
Skin ConditionSkin AbnormalitiesMalignancy+2 more
AI Labs Group S.L 131
Testing effectiveness (Phase 2)WithdrawnNCT01355562
What this trial is testing

Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer

Who this might be right for
MelanomaMetastatic Kidney Cancer
Loma Linda University
Testing effectiveness (Phase 2)Study completedNCT00066196
What this trial is testing

Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma

Who this might be right for
MelanomaMalignant Metastatic Melanoma
MedImmune LLC 110
Not applicableStudy completedNCT02069769
What this trial is testing

Ensuring Communication in Hospice by Oncology Study (ECHO)

Who this might be right for
Ovarian CancerCervical CancerUterine Cancer+3 more
Massachusetts General Hospital 30
Early research (Phase 1)Study completedNCT01295827
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)

Who this might be right for
Cancer, Solid Tumor
Merck Sharp & Dohme LLC 1,260
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00256282
What this trial is testing

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Melanoma
John P. Fruehauf 52
Not applicableLooking for participantsNCT06861023
What this trial is testing

Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma

Who this might be right for
Melanoma
Centre Hospitalier Universitaire de Nice 10
Testing effectiveness (Phase 2)Study completedNCT00003339
What this trial is testing

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 48
Testing effectiveness (Phase 2)Study completedNCT02083354
What this trial is testing

Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

Who this might be right for
CancerMelanoma
Novartis Pharmaceuticals 77
Testing effectiveness (Phase 2)Ended earlyNCT02302339
What this trial is testing

Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Celldex Therapeutics 132
Not applicableStudy completedNCT07428954
What this trial is testing

Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care

Who this might be right for
DermatitisMelanoma (Skin Cancer)Alopecia+10 more
AI Labs Group S.L 16
Testing effectiveness (Phase 2)Study completedNCT00003802
What this trial is testing

Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT02515227
What this trial is testing

Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab

Who this might be right for
Melanoma
Craig L Slingluff, Jr 22
Early research (Phase 1)WithdrawnNCT02839694
What this trial is testing

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

Who this might be right for
Neoplasm MetastasisSarcomaNeoplasms, Germ Cell and Embryonal+1 more
National Cancer Institute (NCI)
Not applicableUnknownNCT05602337
What this trial is testing

A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin Cancer

Who this might be right for
Melanoma and Other Malignant Neoplasms of Skin
DermTech 180
Next Page